Eikon Therapeutics, a Bay Area biotech startup with $1.1 billion in funding, is laying off dozens of employees and pointing ...

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) has announced promising results from its Phase 2 trial of NBI-1117568, a first-in ...

WALTHAM, Mass. and BOULDER, Colo., May 29, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology ...

Job cuts at home-grown pharma companies like Arvinas and RallyBio and federal policies challenge CT biotech 'ecosystem' that ...

Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing ...

The biotechnology company BeiGene, founded in China, is moving its legal headquarters from the Cayman Islands to Basel.

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...

Colossal Biosciences is a trailblazing company that's pushing the boundaries of genetic engineering and shattering them.

Bankrupt genetic testing company 23andMe has been sold to Regeneron Pharmaceuticals for $256 million. The deal includes ...

Krystal Biotech's KRYS short percent of float has risen 9.9% since its last report. The company recently reported that it has ...

Leveraging Northway Biotech’s 20+ years of CDMO expertise, Kaida BioPharma is advancing KAD101, a targeted therapy for ...

Ventyx Biosciences, Inc.’s VTYX share price has dipped by 5.05%, which has investors questioning if this is right time to buy ...